The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Non Narcotic Analgesics-Global Market Insights and Sales Trends 2025
Synopsis
Analgesics mainly work in the central or peripheral nervous system, selective inhibition and relief of a variety of pain, pain relief and fear of tension and anxiety pain drugs.
The global Non Narcotic Analgesics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Non Narcotic Analgesics in various end use industries. The expanding demands from the Hospital, Medical Center and Others,, are propelling Non Narcotic Analgesics market. Non Steroid Antiinflammatory Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Steroid Antiinflammatory Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non Narcotic Analgesics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non Narcotic Analgesics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non Narcotic Analgesics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non Narcotic Analgesics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non Narcotic Analgesics covered in this report include Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer, Reckitt Benckiser and Endo Pharmaceuticals, etc.
The global Non Narcotic Analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi S.A.
Novartis AG
GlaxoSmithKline PLC
Pfizer
Reckitt Benckiser
Endo Pharmaceuticals
Global Non Narcotic Analgesics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non Narcotic Analgesics market, Segment by Type:
Non Steroid Antiinflammatory Drug
Steroid Antiinflammatory Drug
Global Non Narcotic Analgesics market, by Application
Hospital
Medical Center
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Non Narcotic Analgesics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Non Narcotic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Analgesics mainly work in the central or peripheral nervous system, selective inhibition and relief of a variety of pain, pain relief and fear of tension and anxiety pain drugs.
The global Non Narcotic Analgesics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Non Narcotic Analgesics in various end use industries. The expanding demands from the Hospital, Medical Center and Others,, are propelling Non Narcotic Analgesics market. Non Steroid Antiinflammatory Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Steroid Antiinflammatory Drug segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Non Narcotic Analgesics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Non Narcotic Analgesics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Non Narcotic Analgesics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Non Narcotic Analgesics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Non Narcotic Analgesics covered in this report include Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Pfizer, Reckitt Benckiser and Endo Pharmaceuticals, etc.
The global Non Narcotic Analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi S.A.
Novartis AG
GlaxoSmithKline PLC
Pfizer
Reckitt Benckiser
Endo Pharmaceuticals
Global Non Narcotic Analgesics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non Narcotic Analgesics market, Segment by Type:
Non Steroid Antiinflammatory Drug
Steroid Antiinflammatory Drug
Global Non Narcotic Analgesics market, by Application
Hospital
Medical Center
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Non Narcotic Analgesics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Non Narcotic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Non Narcotic Analgesics Market Overview
1.1 Non Narcotic Analgesics Product Overview
1.2 Non Narcotic Analgesics Market Segment by Type
1.2.1 Non Steroid Antiinflammatory Drug
1.2.2 Steroid Antiinflammatory Drug
1.3 Global Non Narcotic Analgesics Market Size by Type
1.3.1 Global Non Narcotic Analgesics Market Size Overview by Type (2018-2029)
1.3.2 Global Non Narcotic Analgesics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Non Narcotic Analgesics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Non Narcotic Analgesics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Non Narcotic Analgesics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Non Narcotic Analgesics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Non Narcotic Analgesics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Non Narcotic Analgesics Sales Breakdown by Type (2018-2023)
2 Global Non Narcotic Analgesics Market Competition by Company
2.1 Global Top Players by Non Narcotic Analgesics Sales (2018-2023)
2.2 Global Top Players by Non Narcotic Analgesics Revenue (2018-2023)
2.3 Global Top Players by Non Narcotic Analgesics Price (2018-2023)
2.4 Global Top Manufacturers Non Narcotic Analgesics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non Narcotic Analgesics Market Competitive Situation and Trends
2.5.1 Non Narcotic Analgesics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Non Narcotic Analgesics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non Narcotic Analgesics as of 2022)
2.7 Date of Key Manufacturers Enter into Non Narcotic Analgesics Market
2.8 Key Manufacturers Non Narcotic Analgesics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Non Narcotic Analgesics Status and Outlook by Region
3.1 Global Non Narcotic Analgesics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Non Narcotic Analgesics Historic Market Size by Region
3.2.1 Global Non Narcotic Analgesics Sales in Volume by Region (2018-2023)
3.2.2 Global Non Narcotic Analgesics Sales in Value by Region (2018-2023)
3.2.3 Global Non Narcotic Analgesics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Non Narcotic Analgesics Forecasted Market Size by Region
3.3.1 Global Non Narcotic Analgesics Sales in Volume by Region (2024-2029)
3.3.2 Global Non Narcotic Analgesics Sales in Value by Region (2024-2029)
3.3.3 Global Non Narcotic Analgesics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Non Narcotic Analgesics by Application
4.1 Non Narcotic Analgesics Market Segment by Application
4.1.1 Hospital
4.1.2 Medical Center
4.1.3 Others
4.2 Global Non Narcotic Analgesics Market Size by Application
4.2.1 Global Non Narcotic Analgesics Market Size Overview by Application (2018-2029)
4.2.2 Global Non Narcotic Analgesics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Non Narcotic Analgesics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Non Narcotic Analgesics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Non Narcotic Analgesics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Non Narcotic Analgesics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Non Narcotic Analgesics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Non Narcotic Analgesics Sales Breakdown by Application (2018-2023)
5 North America Non Narcotic Analgesics by Country
5.1 North America Non Narcotic Analgesics Historic Market Size by Country
5.1.1 North America Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Non Narcotic Analgesics Sales in Volume by Country (2018-2023)
5.1.3 North America Non Narcotic Analgesics Sales in Value by Country (2018-2023)
5.2 North America Non Narcotic Analgesics Forecasted Market Size by Country
5.2.1 North America Non Narcotic Analgesics Sales in Volume by Country (2024-2029)
5.2.2 North America Non Narcotic Analgesics Sales in Value by Country (2024-2029)
6 Europe Non Narcotic Analgesics by Country
6.1 Europe Non Narcotic Analgesics Historic Market Size by Country
6.1.1 Europe Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Non Narcotic Analgesics Sales in Volume by Country (2018-2023)
6.1.3 Europe Non Narcotic Analgesics Sales in Value by Country (2018-2023)
6.2 Europe Non Narcotic Analgesics Forecasted Market Size by Country
6.2.1 Europe Non Narcotic Analgesics Sales in Volume by Country (2024-2029)
6.2.2 Europe Non Narcotic Analgesics Sales in Value by Country (2024-2029)
7 Asia-Pacific Non Narcotic Analgesics by Region
7.1 Asia-Pacific Non Narcotic Analgesics Historic Market Size by Region
7.1.1 Asia-Pacific Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Non Narcotic Analgesics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Non Narcotic Analgesics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Non Narcotic Analgesics Forecasted Market Size by Region
7.2.1 Asia-Pacific Non Narcotic Analgesics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Non Narcotic Analgesics Sales in Value by Region (2024-2029)
8 Latin America Non Narcotic Analgesics by Country
8.1 Latin America Non Narcotic Analgesics Historic Market Size by Country
8.1.1 Latin America Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Non Narcotic Analgesics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Non Narcotic Analgesics Sales in Value by Country (2018-2023)
8.2 Latin America Non Narcotic Analgesics Forecasted Market Size by Country
8.2.1 Latin America Non Narcotic Analgesics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Non Narcotic Analgesics Sales in Value by Country (2024-2029)
9 Middle East and Africa Non Narcotic Analgesics by Country
9.1 Middle East and Africa Non Narcotic Analgesics Historic Market Size by Country
9.1.1 Middle East and Africa Non Narcotic Analgesics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Non Narcotic Analgesics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Non Narcotic Analgesics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Non Narcotic Analgesics Forecasted Market Size by Country
9.2.1 Middle East and Africa Non Narcotic Analgesics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Non Narcotic Analgesics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi S.A.
10.1.1 Sanofi S.A. Company Information
10.1.2 Sanofi S.A. Introduction and Business Overview
10.1.3 Sanofi S.A. Non Narcotic Analgesics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi S.A. Non Narcotic Analgesics Products Offered
10.1.5 Sanofi S.A. Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Non Narcotic Analgesics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis AG Non Narcotic Analgesics Products Offered
10.2.5 Novartis AG Recent Development
10.3 GlaxoSmithKline PLC
10.3.1 GlaxoSmithKline PLC Company Information
10.3.2 GlaxoSmithKline PLC Introduction and Business Overview
10.3.3 GlaxoSmithKline PLC Non Narcotic Analgesics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline PLC Non Narcotic Analgesics Products Offered
10.3.5 GlaxoSmithKline PLC Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Non Narcotic Analgesics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Non Narcotic Analgesics Products Offered
10.4.5 Pfizer Recent Development
10.5 Reckitt Benckiser
10.5.1 Reckitt Benckiser Company Information
10.5.2 Reckitt Benckiser Introduction and Business Overview
10.5.3 Reckitt Benckiser Non Narcotic Analgesics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Reckitt Benckiser Non Narcotic Analgesics Products Offered
10.5.5 Reckitt Benckiser Recent Development
10.6 Endo Pharmaceuticals
10.6.1 Endo Pharmaceuticals Company Information
10.6.2 Endo Pharmaceuticals Introduction and Business Overview
10.6.3 Endo Pharmaceuticals Non Narcotic Analgesics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Endo Pharmaceuticals Non Narcotic Analgesics Products Offered
10.6.5 Endo Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Non Narcotic Analgesics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Non Narcotic Analgesics Industrial Chain Analysis
11.4 Non Narcotic Analgesics Market Dynamics
11.4.1 Non Narcotic Analgesics Industry Trends
11.4.2 Non Narcotic Analgesics Market Drivers
11.4.3 Non Narcotic Analgesics Market Challenges
11.4.4 Non Narcotic Analgesics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Non Narcotic Analgesics Distributors
12.3 Non Narcotic Analgesics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
